Attorney Authored

Against the Backdrop of a ‘National Emergency,’ Are Opioid Manufacturers Ready for the Enforcement Spotlight?

By Gary Giampetruzzi , Jane H. Yoon, and Sandra Gonzalez

On Thursday, August 10, 2017, President Trump announced his intention to designate the opioid crisis a ‘‘national emergency.’’ Hours later, the White House issued a statement that the President had ‘‘instructed his administration to use all appropriate emergency and other authorities to respond to the crisis caused by the opioid epidemic.’’ This has become, as recognized on the evening news each day, in the homes of people across all sectors of our society, a national crisis of increasingly epic proportions.